marketcaparena
Search

    STE

    STERIS plc

    Company overview

    Market capitalization
    $20.57B
    Employees
    17,937
    Latest publication
    2026-09-29
    About STERIS plc

    STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USDQ4 20232023-03-31 · USD
    Total Revenue1,492,700,000USD1,588,400,000USD1,496,100,000USD1,460,300,000USD1,480,531,000USD1,370,570,000USD1,328,912,000USD1,384,837,000USD
    Cost Of Revenue808,600,000USD891,300,000USD840,600,000USD814,400,000USD839,320,000USD760,238,000USD750,121,000USD796,775,000USD
    Gross Profit684,200,000USD697,100,000USD655,500,000USD645,900,000USD641,211,000USD610,332,000USD578,791,000USD588,062,000USD
    Research Development28,600,000USD28,800,000USD29,500,000USD28,200,000USD27,686,000USD27,358,000USD27,031,000USD26,388,000USD
    Selling General Administrative369,700,000USD351,800,000USD352,300,000USD349,700,000USD312,009,000USD335,450,000USD329,298,000USD314,246,000USD
    Total Operating Expenses398,300,000USD380,600,000USD382,300,000USD380,100,000USD425,060,000USD365,039,000USD359,125,000USD362,660,000USD
    Operating Income285,800,000USD316,800,000USD271,000,000USD268,000,000USD216,151,000USD245,293,000USD219,666,000USD225,402,000USD
    Total Other Income Expense Net-12,300,000USD-12,300,000USD-13,200,000USD-14,900,000USD-18,840,000USD-16,548,000USD-24,774,000USD-30,281,000USD
    Interest Expense15,800,000USD15,100,000USD14,800,000USD14,900,000USD17,115,000USD19,094,000USD19,668,000USD30,281,000USD
    Income Before Tax273,500,000USD304,500,000USD257,800,000USD253,100,000USD197,311,000USD228,745,000USD194,892,000USD195,121,000USD
    Income Tax Expense72,500,000USD84,200,000USD63,500,000USD60,600,000USD50,450,000USD55,384,000USD43,506,000USD8,157,000USD
    Net Income201,000,000USD220,300,000USD192,800,000USD191,900,000USD145,672,000USD173,534,000USD150,034,000USD187,225,000USD
    Minority Interest900,000USD-100,000USD-1,500,000USD-600,000USD-403,000USD249,000USD-1,139,000USD261,000USD
    Net Income Applicable To Common Shares200,100,000USD—192,900,000USD191,900,000USD145,672,000USD173,534,000USD150,034,000USD187,225,000USD
    Interest Income—2,800,000USD12,000,000USD2,400,000USD3,533,000USD2,434,000USD1,126,000USD30,281,000USD
    Net Interest Income—-12,300,000USD-12,000,000USD-12,500,000USD-13,582,000USD-16,660,000USD-18,542,000USD-30,281,000USD
    Tax Provision—84,200,000USD63,500,000USD60,600,000USD50,450,000USD55,384,000USD43,506,000USD8,157,000USD
    Net Income From Continuing Ops—220,300,000USD194,300,000USD192,500,000USD146,861,000USD173,361,000USD151,386,000USD186,964,000USD
    Ebit—319,600,000USD269,200,000USD268,000,000USD214,426,000USD247,839,000USD214,560,000USD225,402,000USD
    Ebitda—680,100,000USD391,200,000USD389,700,000USD336,775,000USD373,752,000USD329,813,000USD367,606,000USD
    Depreciation And Amortization—360,500,000USD122,000,000USD121,700,000USD122,349,000USD125,913,000USD115,253,000USD142,204,000USD
    Reconciled Depreciation—123,400,000USD122,000,000USD121,700,000USD122,349,000USD125,913,000USD115,255,000USD142,204,000USD
    Selling And Marketing Expenses————19,949,000USD——21,668,000USD
    Unclassified Operating Expenses————65,416,000USD———
    Non Operating Income Net Other———————352,000USD
    Source0001628280-26-054830DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USDFY 20182018-03-31 · USDFY 20172017-03-31 · USDFY 20162016-03-31 · USD
    Total Revenue5,935,900,000USD5,459,515,000USD3,107,519,000USD3,030,895,000USD2,782,170,000USD2,619,996,000USD2,612,756,000USD2,238,764,000USD
    Cost Of Revenue3,309,400,000USD3,056,751,000USD1,764,419,000USD1,710,899,000USD1,607,184,000USD1,527,250,000USD1,586,543,000USD1,343,283,000USD
    Gross Profit2,626,500,000USD2,402,764,000USD1,343,100,000USD1,319,996,000USD1,174,986,000USD1,092,746,000USD1,026,213,000USD895,481,000USD
    Research Development112,900,000USD107,648,000USD66,326,000USD65,546,000USD63,038,000USD60,782,000USD59,397,000USD56,664,000USD
    Selling General Administrative1,407,700,000USD1,303,168,000USD724,525,000USD704,079,000USD659,246,000USD604,881,000USD639,335,000USD533,034,000USD
    Total Operating Expenses1,524,700,000USD1,536,123,000USD794,732,000USD782,950,000USD763,962,000USD692,863,000USD800,007,000USD682,554,000USD
    Operating Income1,101,800,000USD866,641,000USD548,368,000USD537,046,000USD411,024,000USD399,883,000USD226,206,000USD212,927,000USD
    Interest Income9,800,000USD8,402,000USD6,345,000USD38,292,000USD41,995,000USD44,901,000USD41,560,000USD41,043,000USD
    Interest Expense60,700,000USD86,261,000USD37,180,000USD40,279,000USD45,015,000USD50,629,000USD44,520,000USD42,708,000USD
    Net Interest Income-50,900,000USD-77,859,000USD-30,835,000USD-38,292,000USD-41,995,000USD-48,472,000USD-42,949,000USD—
    Income Before Tax1,047,300,000USD796,207,000USD517,533,000USD498,754,000USD369,029,000USD354,982,000USD184,646,000USD171,884,000USD
    Income Tax Expense262,200,000USD184,650,000USD120,663,000USD90,895,000USD64,283,000USD63,360,000USD74,015,000USD60,299,000USD
    Tax Provision262,200,000USD184,650,000USD120,663,000USD90,876,000USD64,394,000USD82,273,000USD74,015,000USD60,299,000USD
    Net Income785,100,000USD614,641,000USD397,400,000USD407,659,000USD304,051,000USD290,915,000USD109,965,000USD110,763,000USD
    Net Income From Continuing Ops785,100,000USD611,557,000USD396,870,000USD407,805,000USD305,076,000USD291,622,000USD110,631,000USD111,585,000USD
    Ebit1,108,000,000USD882,468,000USD554,713,000USD539,033,000USD414,044,000USD405,611,000USD229,166,000USD214,592,000USD
    Ebitda1,594,500,000USD1,358,683,000USD773,950,000USD736,268,000USD639,965,000USD583,943,000USD417,308,000USD358,332,000USD
    Depreciation And Amortization486,500,000USD476,215,000USD219,237,000USD197,235,000USD225,921,000USD178,332,000USD188,142,000USD143,740,000USD
    Reconciled Depreciation486,500,000USD476,215,000USD219,237,000USD197,235,000USD225,921,000USD178,332,000USD——
    Total Other Income Expense Net-54,500,000USD-70,434,000USD-30,835,000USD-38,292,000USD-41,995,000USD-44,901,000USD-41,560,000USD-41,043,000USD
    Minority Interest-2,800,000USD-1,433,000USD-530,000USD12,848,000USD7,988,000USD11,340,000USD11,431,000USD15,858,000USD
    Selling And Marketing Expenses—19,949,000USD6,795,000USD12,652,000USD10,691,000USD10,886,000USD12,622,000USD10,785,000USD
    Unclassified Operating Expenses—105,358,000USD——30,987,000USD16,314,000USD88,653,000USD82,071,000USD
    Net Income Applicable To Common Shares—614,641,000USD397,400,000USD407,605,000USD303,721,000USD290,915,000USD109,965,000USD110,763,000USD
    Non Operating Income Net Other——6,345,000USD1,987,000USD3,020,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USDQ1 20252024-06-30 · USD
    Total Assets10,736,100,000USD10,737,200,000USD10,591,400,000USD10,410,700,000USD10,146,811,000USD10,008,362,000USD10,242,145,000USD10,108,601,000USD
    Cash And Equivalents482,300,000USD—423,700,000USD319,200,000USD171,701,000USD155,178,000USD172,195,000USD—
    Total Current Assets2,445,800,000USD2,394,600,000USD2,286,200,000USD2,106,300,000USD2,000,765,000USD1,897,853,000USD1,937,869,000USD1,940,494,000USD
    Other Non Current Assets215,100,000USD———————
    Total Liabilities3,514,800,000USD———————
    Total Current Liabilities1,283,300,000USD1,145,000,000USD922,300,000USD888,900,000USD1,022,173,000USD891,120,000USD805,483,000USD834,360,000USD
    Other Current Liabilities420,500,000USD———————
    Other Non Current Liabilities75,200,000USD———————
    Total Stockholder Equity7,206,700,000USD7,183,600,000USD7,167,900,000USD7,009,100,000USD6,603,405,000USD6,416,101,000USD6,593,489,000USD6,354,597,000USD
    Total Equity Including Noncontrolling Interest7,221,300,000USD———————
    Long Term Debt1,650,200,000USD1,812,900,000USD1,898,400,000USD1,897,200,000USD1,918,701,000USD2,038,725,000USD2,156,158,000USD2,235,601,000USD
    Net Receivables1,013,200,000USD1,092,800,000USD990,600,000USD947,300,000USD1,043,961,000USD915,199,000USD923,340,000USD892,606,000USD
    Inventory712,100,000USD631,800,000USD673,500,000USD658,500,000USD581,329,000USD649,558,000USD688,933,000USD698,587,000USD
    Property Plant Equipment Net2,322,500,000USD2,316,400,000USD2,288,100,000USD2,252,100,000USD2,112,932,000USD2,075,612,000USD2,088,903,000USD1,999,236,000USD
    Goodwill4,189,200,000USD———————
    Intangible Assets1,563,500,000USD1,620,000,000USD1,691,500,000USD1,749,000,000USD1,854,390,000USD1,923,020,000USD2,003,669,000USD2,048,990,000USD
    Accounts Payable344,100,000USD338,800,000USD285,100,000USD308,900,000USD280,770,000USD238,298,000USD235,070,000USD231,720,000USD
    Short Term Debt35,600,000USD154,700,000USD34,400,000USD35,300,000USD159,202,000USD157,451,000USD110,509,000USD109,705,000USD
    Common Stock4,179,500,000USD—4,339,800,000USD4,358,700,000USD4,420,413,000USD4,404,687,000USD4,490,999,000USD4,499,580,000USD
    Retained Earnings3,154,500,000USD3,015,900,000USD2,857,400,000USD2,726,400,000USD2,475,330,000USD2,385,664,000USD2,268,326,000USD2,178,087,000USD
    Accumulated Other Comprehensive Income-127,300,000USD-113,100,000USD-42,700,000USD-75,999,999USD-292,338,000USD-374,250,000USD-165,836,000USD-323,070,000USD
    Other Current Assets—230,400,000USD198,400,000USD181,300,000USD203,774,000USD177,918,000USD153,401,000USD150,973,000USD
    Total Liab—3,540,000,000USD3,423,500,000USD3,388,100,000USD3,531,054,000USD3,579,816,000USD3,631,683,000USD3,738,156,000USD
    Other Current Liab—592,400,000USD544,000,000USD495,200,000USD524,699,000USD415,338,000USD381,411,000USD366,612,000USD
    Capital Stock—4,280,900,000USD4,339,800,000USD4,358,700,000USD4,420,413,000USD4,404,687,000USD4,490,999,000USD4,499,580,000USD
    Good Will—4,194,800,000USD4,232,000,000USD4,215,300,000USD4,095,678,000USD4,044,198,000USD4,151,437,000USD4,056,754,000USD
    Cash—439,600,000USD423,700,000USD319,200,000USD171,701,000USD155,178,000USD172,195,000USD198,328,000USD
    Cash And Short Term Investments—439,600,000USD423,700,000USD319,200,000USD171,701,000USD155,178,000USD172,195,000USD198,328,000USD
    Current Deferred Revenue—59,100,000USD58,800,000USD49,500,000USD57,502,000USD80,033,000USD72,643,000USD69,323,000USD
    Net Debt—1,647,500,000USD1,630,000,000USD1,739,400,000USD2,030,839,000USD2,164,715,000USD2,227,620,000USD2,286,340,000USD
    Short Long Term Debt—118,900,000USD——125,000,000USD125,000,000USD80,000,000USD80,000,000USD
    Short Long Term Debt Total—2,087,100,000USD2,053,700,000USD2,058,600,000USD2,202,540,000USD2,319,893,000USD2,399,815,000USD2,484,668,000USD
    Property Plant Equipment Gross—4,261,100,000USD4,205,600,000USD4,116,700,000USD3,844,045,000USD3,759,478,000USD3,755,181,000USD3,604,790,000USD
    Common Stock Shares Outstanding—98,400,000shares98,800,000shares98,800,000shares98,756,000shares98,942,000shares99,204,000shares99,376,000shares
    Non Current Assets Total—8,342,600,000USD8,305,200,000USD8,304,400,000USD8,146,046,000USD8,110,509,000USD8,304,276,000USD8,168,107,000USD
    Non Current Liabilities Total—2,394,800,000USD2,501,200,000USD2,499,200,000USD2,508,881,000USD2,688,696,000USD2,826,200,000USD2,903,796,000USD
    Non Current Liabilities Other—22,000,000USD16,400,000USD13,500,000USD12,712,000USD21,625,000USD22,067,000USD21,279,000USD
    Non Currrent Assets Other—211,400,000USD93,600,000USD72,000,000USD68,746,000USD67,679,000USD60,267,000USD63,127,000USD
    Net Working Capital—1,249,600,000USD1,363,900,000USD1,217,400,000USD978,592,000USD1,006,733,000USD1,132,386,000USD1,106,134,000USD
    Unclassified Current Liabilities—-118,900,000USD——-125,000,000USD-125,000,000USD-74,150,000USD-23,000,000USD
    Unclassified Non Current Liabilities—559,900,000USD586,400,000USD588,500,000USD577,468,000USD628,346,000USD647,975,000USD646,916,000USD
    Other Assets——93,600,000USD88,000,000USD83,046,000USD67,679,000USD60,267,000USD—
    Unclassified Non Current Assets——-93,600,000USD—————
    Unclassified Equity——-4,326,400,000USD-4,358,700,001USD-4,420,413,000USD-4,404,687,000USD-4,490,999,000USD-4,499,580,000USD
    Source0001628280-26-054830DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Assets10,737,200,000USD10,146,811,000USD11,063,697,000USD10,821,839,000USD11,423,594,000USD6,574,471,000USD5,425,582,000USD5,073,071,000USD
    Intangible Assets1,620,000,000USD1,854,390,000USD2,119,282,000USD2,955,780,000USD3,328,537,000USD898,406,000USD565,473,000USD604,614,000USD
    Other Current Assets230,400,000USD203,774,000USD979,253,000USD179,277,000USD156,637,000USD66,750,000USD54,430,000USD60,029,000USD
    Total Liab3,540,000,000USD3,531,054,000USD4,748,351,000USD4,734,667,000USD4,878,957,000USD2,683,003,000USD2,018,858,000USD1,887,273,000USD
    Total Stockholder Equity7,183,600,000USD6,603,405,000USD6,302,164,000USD6,087,172,000USD6,532,356,000USD3,891,468,000USD3,406,724,000USD3,185,798,000USD
    Other Current Liab592,400,000USD524,699,000USD478,127,000USD394,980,000USD379,474,000USD335,704,000USD281,158,000USD312,283,000USD
    Capital Stock4,280,900,000USD4,420,413,000USD4,543,176,000USD4,486,375,000USD4,742,920,000USD2,002,825,000USD1,982,164,000USD1,998,564,000USD
    Retained Earnings3,015,900,000USD2,475,330,000USD2,087,645,000USD1,911,533,000USD1,999,244,000USD1,939,408,000USD1,647,175,000USD1,339,024,000USD
    Good Will4,194,800,000USD4,095,678,000USD4,070,712,000USD3,879,219,000USD4,404,343,000USD3,026,049,000USD2,356,085,000USD2,322,928,000USD
    Cash439,600,000USD171,701,000USD207,020,000USD208,357,000USD348,320,000USD220,531,000USD319,581,000USD220,633,000USD
    Cash And Short Term Investments439,600,000USD171,701,000USD207,020,000USD208,357,000USD348,320,000USD220,531,000USD319,581,000USD220,633,000USD
    Total Current Assets2,394,600,000USD2,000,765,000USD2,869,123,000USD2,011,442,000USD1,878,997,000USD1,211,754,000USD1,208,751,000USD1,053,735,000USD
    Total Current Liabilities1,145,000,000USD1,022,173,000USD931,127,000USD861,844,000USD922,222,000USD577,920,000USD503,607,000USD465,196,000USD
    Current Deferred Revenue59,100,000USD57,502,000USD70,460,000USD92,283,000USD110,791,000USD62,492,000USD53,299,000USD55,333,000USD
    Net Debt1,647,500,000USD2,030,839,000USD3,176,147,000USD2,810,298,000USD2,931,564,000USD1,430,009,000USD830,940,000USD962,594,000USD
    Short Term Debt154,700,000USD159,202,000USD117,177,000USD94,961,000USD179,347,000USD22,774,000USD19,809,000USD55,333,000USD
    Short Long Term Debt118,900,000USD125,000,000USD85,938,000USD60,000,000USD142,875,000USD———
    Short Long Term Debt Total2,087,100,000USD2,202,540,000USD3,383,167,000USD3,113,616,000USD3,279,884,000USD1,673,314,000USD1,170,330,000USD1,238,560,000USD
    Long Term Debt1,812,900,000USD1,918,701,000USD3,120,162,000USD3,018,655,000USD2,945,481,000USD1,650,540,000USD1,150,521,000USD1,183,227,000USD
    Net Receivables1,092,800,000USD1,043,961,000USD1,008,315,000USD928,315,000USD799,041,000USD609,406,000USD586,481,000USD564,830,000USD
    Inventory631,800,000USD581,329,000USD674,535,000USD695,493,000USD574,999,000USD315,067,000USD248,259,000USD208,243,000USD
    Accounts Payable338,800,000USD280,770,000USD251,723,000USD279,620,000USD225,737,000USD156,950,000USD149,341,000USD152,913,000USD
    Property Plant Equipment Net2,316,400,000USD2,112,932,000USD1,938,381,000USD1,897,253,000USD1,741,056,000USD1,385,542,000USD1,243,692,000USD1,031,582,000USD
    Property Plant Equipment Gross4,261,100,000USD3,844,045,000USD3,512,328,000USD1,705,512,000USD1,741,056,000USD1,385,542,000USD1,243,692,000USD1,031,582,000USD
    Accumulated Other Comprehensive Income-113,100,000USD-292,338,000USD-328,657,000USD-320,710,000USD-209,808,000USD-61,243,000USD-235,463,000USD-159,778,000USD
    Common Stock Shares Outstanding98,700,000shares99,069,000shares99,359,000shares100,246,000shares98,326,000shares85,898,000shares85,641,000shares85,468,000shares
    Non Current Assets Total8,342,600,000USD8,146,046,000USD8,194,574,000USD8,810,397,000USD9,544,597,000USD5,362,717,000USD4,216,831,000USD4,019,336,000USD
    Non Current Liabilities Total2,394,800,000USD2,508,881,000USD3,817,224,000USD3,872,823,000USD3,956,735,000USD2,105,083,000USD1,515,251,000USD1,422,077,000USD
    Non Current Liabilities Other22,000,000USD12,712,000USD21,037,000USD854,168,000USD1,040,259,000USD88,010,000USD27,892,000USD18,325,000USD
    Non Currrent Assets Other211,400,000USD68,746,000USD66,199,000USD78,145,000USD62,532,000USD52,720,000USD51,581,000USD60,212,000USD
    Net Working Capital1,249,600,000USD978,592,000USD1,937,996,000USD1,149,598,000USD956,775,000USD633,834,000USD705,144,000USD588,539,000USD
    Unclassified Current Liabilities-118,900,000USD-125,000,000USD-72,298,000USD-60,000,000USD-116,002,000USD——-110,666,000USD
    Unclassified Non Current Liabilities559,900,000USD577,468,000USD676,025,000USD-1,311,213,000USD-1,069,264,000USD-324,870,000USD-74,048,000USD-169,363,000USD
    Common Stock—4,420,413,000USD4,543,176,000USD4,486,375,000USD4,742,920,000USD2,002,825,000USD1,982,164,000USD1,998,564,000USD
    Other Assets—83,046,000USD1USD78,145,000USD70,661,000USD52,720,000USD51,581,000USD60,212,000USD
    Cash And Equivalents—171,701,000USD207,020,000USD208,357,000USD348,320,000USD220,531,000USD319,581,000USD220,633,000USD
    Unclassified Equity—-4,420,413,000USD-4,543,176,000USD-4,476,401,000USD-4,742,920,000USD-1,992,347,000USD-1,969,316,000USD-1,990,576,000USD
    Deferred Long Term Liab———617,538,000USD—236,860,000USD160,270,000USD151,038,000USD
    Other Liab———693,675,000USD1,040,259,000USD454,543,000USD250,616,000USD238,850,000USD
    Net Tangible Assets———2,197,979,000USD-1,217,248,000USD854,941,000USD472,318,000USD250,268,000USD
    Unclassified Non Current Assets——————-51,581,000USD-60,212,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USDQ1 20252024-06-30 · USD
    Depreciation123,800,000USD360,500,000USD122,000,000USD121,700,000USD122,349,000USD125,913,000USD115,253,000USD112,700,000USD
    Stock Based Compensation12,800,000USD45,000,000USD15,700,000USD21,200,000USD9,791,000USD15,334,000USD20,772,000USD11,500,000USD
    Deferred Income Tax600,000USD———————
    Other Non Cash Items-11,200,000USD-436,200,000USD2,200,000USD-900,000USD17,059,000USD-7,452,000USD10,127,000USD-11,300,000USD
    Change To Account Receivables90,000,000USD233,100,000USD-15,500,000USD-5,300,000USD-108,110,000USD-3,211,000USD-25,194,000USD107,700,000USD
    Change To Inventory-73,300,000USD-103,200,000USD-1,800,000USD-18,200,000USD73,799,000USD17,950,000USD15,423,000USD-34,100,000USD
    Change To Liabilities9,100,000USD———————
    Change In Working Capital13,000,000USD145,900,000USD-36,000,000USD-46,500,000USD18,266,000USD27,460,000USD-46,613,000USD67,400,000USD
    Operating Cash Flow367,100,000USD———————
    Capital Expenditures-87,500,000USD-90,200,000USD-98,700,000USD-86,500,000USD-70,885,000USD-89,231,000USD-101,875,000USD-108,100,000USD
    Net Investments-5,000,000USD———————
    Other Investing Activities-16,000,000USD———————
    Investing Cash Flow-108,500,000USD———————
    Net Common Stock Issuance-131,000,000USD———————
    Common Dividends Paid-61,400,000USD———————
    Other Financing Activities1,300,000USD———————
    Unclassified Financing Cash Flow-22,400,000USD—15,400,000USD————-891,300,000USD
    Financing Cash Flow-213,500,000USD———————
    Effect Of Forex Changes On Cash-2,300,000USD———————
    Change In Cash42,800,000USD15,900,000USD104,500,000USD39,500,000USD16,523,000USD-17,017,000USD-26,105,000USD-8,700,000USD
    End Cash Flow482,300,000USD———————
    Net Income—220,300,000USD194,400,000USD192,400,000USD146,075,000USD173,285,000USD151,214,000USD145,500,000USD
    Total Cash From Operating Activities—335,400,000USD298,200,000USD287,800,000USD260,781,000USD332,838,000USD250,768,000USD303,700,000USD
    Free Cash Flow—245,200,000USD199,500,000USD201,300,000USD189,896,000USD243,607,000USD148,893,000USD195,600,000USD
    Investments—-127,200,000USD-5,000,000USD-88,300,000USD-69,800,000USD-123,904,000USD-105,352,000USD687,829,000USD
    Total Cashflows From Investing Activities—-217,200,000USD-98,500,000USD-88,300,000USD-69,800,000USD-123,904,000USD-105,323,000USD687,800,000USD
    Net Borrowings—37,800,000USD0USD-4,300,000USD-127,312,000USD-54,117,000USD-91,700,000USD—
    Total Cash From Financing Activities—-97,900,000USD-98,000,000USD-159,200,000USD-178,071,000USD-214,397,000USD-180,996,000USD-998,900,000USD
    Dividends Paid—-61,800,000USD-61,900,000USD-61,900,000USD-56,006,000USD-56,196,000USD-56,273,000USD-51,400,000USD
    Sale Purchase Of Stock—-74,300,000USD-50,100,000USD-92,900,000USD-263,000USD-100,433,000USD-46,425,000USD-64,200,000USD
    Begin Period Cash Flow—423,700,000USD319,200,000USD279,700,000USD155,178,000USD172,195,000USD198,300,000USD207,000,000USD
    End Period Cash Flow—439,600,000USD423,700,000USD319,200,000USD171,701,000USD155,178,000USD172,195,000USD198,300,000USD
    Other Cashflows From Investing Activities—-100,000USD10,600,000USD-300,000USD-1,559,000USD4,000USD814,377,000USD809,571,000USD
    Other Cashflows From Financing Activities—-200,000USD-1,400,000USD-100,000USD5,510,000USD-3,696,000USD13,447,000USD8,000,000USD
    Unclassified Investing Cash Flow——-5,400,000USD86,800,000USD72,444,000USD89,227,000USD-712,473,000USD-701,500,000USD
    Unclassified Operating Cash Flow————-52,759,000USD——-22,100,000USD
    Source0001628280-26-054830DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Net Income785,100,000USD616,074,000USD380,079,000USD105,813,000USD242,870,000USD396,870,000USD407,805,000USD304,746,000USD
    Depreciation486,500,000USD476,215,000USD565,244,000USD552,897,000USD553,104,000USD-30,206,000USD-33,234,000USD225,921,000USD
    Stock Based Compensation61,700,000USD57,397,000USD56,535,000USD38,951,000USD57,660,000USD25,966,000USD23,811,000USD23,965,000USD
    Other Non Cash Items-2,100,000USD8,434,000USD248,906,000USD495,222,000USD86,617,000USD273,764,000USD232,491,000USD-18,843,000USD
    Change To Account Receivables-25,100,000USD-28,815,000USD-128,069,000USD-133,304,000USD-51,969,000USD12,076,000USD-17,866,000USD-48,486,000USD
    Change To Inventory-24,000,000USD73,072,000USD-37,450,000USD-123,921,000USD-102,922,000USD3,769,000USD-39,067,000USD-14,176,000USD
    Change In Working Capital27,200,000USD66,513,000USD-146,078,000USD-250,023,000USD-148,820,000USD19,006,000USD-49,737,000USD10,338,000USD
    Total Cash From Operating Activities1,341,400,000USD1,148,087,000USD973,274,000USD756,947,000USD684,811,000USD689,640,000USD590,559,000USD539,505,000USD
    Capital Expenditures-369,000,000USD-370,091,000USD-360,326,000USD-361,969,000USD-287,563,000USD-239,262,000USD-214,516,000USD-189,715,000USD
    Free Cash Flow972,400,000USD777,996,000USD612,948,000USD394,978,000USD397,248,000USD450,378,000USD376,043,000USD349,790,000USD
    Investments-134,000,000USD388,773,000USD-887,361,000USD-383,330,000USD-666,559,000USD-4,400,000USD-319,735,000USD-4,955,000USD
    Total Cashflows From Investing Activities-512,500,000USD388,773,000USD-887,361,000USD-383,330,000USD-666,559,000USD-1,154,159,000USD-319,735,000USD-213,224,000USD
    Net Borrowings-122,000,000USD-1,164,429,000USD121,486,000USD150,657,000USD372,181,000USD471,693,000USD-27,781,000USD-112,575,000USD
    Total Cash From Financing Activities-568,200,000USD-1,572,364,000USD-85,186,000USD-498,718,000USD115,830,000USD345,620,000USD-163,146,000USD-294,792,000USD
    Dividends Paid-241,800,000USD-219,875,000USD-200,570,000USD-183,498,000USD-163,169,000USD-133,837,000USD-123,034,000USD-112,503,000USD
    Sale Purchase Of Stock-235,500,000USD-211,321,000USD-11,765,000USD-308,565,000USD-55,777,000USD-14,646,000USD-51,241,000USD-81,494,000USD
    Change In Cash267,900,000USD-35,319,000USD-1,337,000USD-139,963,000USD127,789,000USD-99,050,000USD98,948,000USD19,099,000USD
    Begin Period Cash Flow171,700,000USD207,020,000USD208,357,000USD348,320,000USD220,531,000USD319,581,000USD220,633,000USD201,534,000USD
    End Period Cash Flow439,600,000USD171,701,000USD207,020,000USD208,357,000USD348,320,000USD220,531,000USD319,581,000USD220,633,000USD
    Other Cashflows From Investing Activities100,000USD9,195,000USD7,381,000USD-21,361,000USD-378,996,000USD-910,497,000USD-105,219,000USD-13,286,000USD
    Other Cashflows From Financing Activities-1,800,000USD23,261,000USD5,663,000USD-2,265,000USD1,962,595,000USD-17,162,000USD2,898,000USD11,292,000USD
    Unclassified Operating Cash Flow-17,000,000USD-76,546,000USD-131,412,000USD-185,913,000USD-106,620,000USD—9,423,000USD-6,622,000USD
    Unclassified Investing Cash Flow-9,600,000USD360,896,000USD352,945,000USD383,330,000USD666,559,000USD—319,735,000USD-5,268,000USD
    Unclassified Financing Cash Flow32,900,000USD——-155,047,000USD-2,000,000,000USD39,572,000USD36,012,000USD—
    Change To Liabilities———31,288,000USD14,887,000USD2,703,000USD3,412,000USD80,371,000USD
    Cash And Cash Equivalents Changes———-125,101,000USD—-99,050,000USD98,948,000USD19,099,000USD
    Exchange Rate Changes—————19,849,000USD-8,730,000USD-12,390,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Healthcare Segment Backlog

    Period endPeriodValueUnitSource
    No published observations yet.

    Life Sciences Segment Backlog

    Period endPeriodValueUnitSource
    No published observations yet.

    Remaining Performance Obligations

    Period endPeriodValueUnitSource
    No published observations yet.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2026Yearly · 2026-03-31GeographyIE108,500,000USD0001628280-26-039136
    FY 2026Yearly · 2026-03-31GeographyOtherforeignlocations1,493,700,000USD0001628280-26-039136
    FY 2026Yearly · 2026-03-31GeographyUnited States4,333,800,000USD0001628280-26-039136
    Q4 2026Quarterly · 2026-03-31GeographyIE32,000,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31GeographyOtherforeignlocations410,700,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31GeographyUnited States1,145,900,000USDLegacy provider
    FY 2026Yearly · 2026-03-31ProductProduct3,060,100,000USD0001628280-26-039136
    FY 2026Yearly · 2026-03-31ProductServices2,875,800,000USD0001628280-26-039136
    Q4 2026Quarterly · 2026-03-31ProductProduct845,300,000USDLegacy provider
    Q4 2026Quarterly · 2026-03-31ProductServices743,000,000USDLegacy provider
    FY 2026Yearly · 2026-03-31SegmentApplied Sterilization Technologies1,138,500,000USD0001628280-26-039136
    FY 2026Yearly · 2026-03-31SegmentHealthcare4,208,600,000USD0001628280-26-039136
    FY 2026Yearly · 2026-03-31SegmentLife Science Member588,800,000USD0001628280-26-039136
    Q3 2026Quarterly · 2025-12-31GeographyIE26,700,000USD0001628280-26-006055
    Q3 2026Quarterly · 2025-12-31GeographyInternational382,300,000USD0001628280-26-006055
    Q3 2026Quarterly · 2025-12-31GeographyUnited States1,087,100,000USD0001628280-26-006055
    Q3 2026Quarterly · 2025-12-31ProductProduct778,900,000USD0001628280-26-006055
    Q3 2026Quarterly · 2025-12-31ProductServices717,300,000USD0001628280-26-006055
    Q3 2026Quarterly · 2025-12-31SegmentApplied Sterilization Technologies286,600,000USD0001628280-26-006055
    Q3 2026Quarterly · 2025-12-31SegmentHealthcare1,063,800,000USD0001628280-26-006055
    Q3 2026Quarterly · 2025-12-31SegmentLife Science145,800,000USD0001628280-26-006055
    Q2 2026Quarterly · 2025-09-30GeographyIE27,300,000USD0001628280-25-050160
    Q2 2026Quarterly · 2025-09-30GeographyOtherforeignlocations357,800,000USD0001628280-25-050160
    Q2 2026Quarterly · 2025-09-30GeographyUnited States1,075,200,000USD0001628280-25-050160
    Q2 2026Quarterly · 2025-09-30ProductProduct745,400,000USD0001628280-25-050160
    Q2 2026Quarterly · 2025-09-30ProductServices714,900,000USD0001628280-25-050160
    Q2 2026Quarterly · 2025-09-30SegmentApplied Sterilization Technologies281,500,000USD0001628280-25-050160
    Q2 2026Quarterly · 2025-09-30SegmentHealthcare1,033,800,000USD0001628280-25-050160
    Q2 2026Quarterly · 2025-09-30SegmentLife Science145,000,000USD0001628280-25-050160
    FY 2025Yearly · 2025-03-31GeographyIE107,300,000USD0001628280-26-039136
    FY 2025Yearly · 2025-03-31GeographyOtherforeignlocations1,344,600,000USD0001628280-26-039136
    FY 2025Yearly · 2025-03-31GeographyUnited States4,007,600,000USD0001628280-26-039136
    Q4 2025Quarterly · 2025-03-31GeographyIE38,200,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31GeographyOtherforeignlocations363,700,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31GeographyUnited States1,078,600,000USDLegacy provider
    FY 2025Yearly · 2025-03-31ProductProduct2,871,600,000USD0001628280-26-039136
    FY 2025Yearly · 2025-03-31ProductServices2,587,900,000USD0001628280-26-039136
    Q4 2025Quarterly · 2025-03-31ProductProduct801,100,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31ProductServices679,500,000USDLegacy provider
    FY 2025Yearly · 2025-03-31SegmentApplied Sterilization Technologies1,038,600,000USD0001628280-26-039136
    FY 2025Yearly · 2025-03-31SegmentHealthcare3,878,700,000USD0001628280-26-039136
    FY 2025Yearly · 2025-03-31SegmentLife Science Member542,300,000USD0001628280-26-039136
    Q3 2025Quarterly · 2024-12-31GeographyIE24,100,000USD0001628280-26-006055
    Q3 2025Quarterly · 2024-12-31GeographyInternational343,900,000USD0001628280-26-006055
    Q3 2025Quarterly · 2024-12-31GeographyUnited States1,002,600,000USD0001628280-26-006055
    Q3 2025Quarterly · 2024-12-31ProductProduct718,300,000USD0001628280-26-006055
    Q3 2025Quarterly · 2024-12-31ProductServices652,200,000USD0001628280-26-006055
    Q3 2025Quarterly · 2024-12-31SegmentApplied Sterilization Technologies258,100,000USD0001628280-26-006055
    Q3 2025Quarterly · 2024-12-31SegmentHealthcare976,000,000USD0001628280-26-006055
    Q3 2025Quarterly · 2024-12-31SegmentLife Science136,400,000USD0001628280-26-006055
    Q2 2025Quarterly · 2024-09-30GeographyIE22,800,000USD0001628280-25-050160
    Q2 2025Quarterly · 2024-09-30GeographyOtherforeignlocations326,600,000USD0001628280-25-050160
    Q2 2025Quarterly · 2024-09-30GeographyUnited States979,500,000USD0001628280-25-050160
    Q2 2025Quarterly · 2024-09-30ProductProduct695,900,000USD0001628280-25-050160
    Q2 2025Quarterly · 2024-09-30ProductServices633,000,000USD0001628280-25-050160
    Q2 2025Quarterly · 2024-09-30SegmentApplied Sterilization Technologies256,700,000USD0001628280-25-050160
    Q2 2025Quarterly · 2024-09-30SegmentHealthcare944,200,000USD0001628280-25-050160
    Q2 2025Quarterly · 2024-09-30SegmentLife Science127,900,000USD0001628280-25-050160
    Q1 2025Quarterly · 2024-06-30GeographyIE22,200,000USD0001757898-25-000008
    Q1 2025Quarterly · 2024-06-30GeographyOtherforeignlocations310,400,000USD0001757898-25-000008
    Q1 2025Quarterly · 2024-06-30GeographyUnited States946,900,000USD0001757898-25-000008
    Q1 2025Quarterly · 2024-06-30ProductProduct656,300,000USD0001757898-25-000008
    Q1 2025Quarterly · 2024-06-30ProductServices623,200,000USD0001757898-25-000008
    Q1 2025Quarterly · 2024-06-30SegmentApplied Sterilization Technologies249,803,000USD0001757898-24-000016
    Q1 2025Quarterly · 2024-06-30SegmentHealthcare Member901,221,000USD0001757898-24-000016
    Q1 2025Quarterly · 2024-06-30SegmentLife Science Member128,478,000USD0001757898-24-000016
    FY 2024Yearly · 2024-03-31GeographyIE82,700,000USD0001628280-26-039136
    FY 2024Yearly · 2024-03-31GeographyOtherforeignlocations1,304,600,000USD0001628280-26-039136
    FY 2024Yearly · 2024-03-31GeographyUnited States3,751,400,000USD0001628280-26-039136
    Q4 2024Quarterly · 2024-03-31GeographyIE22,664,000USDLegacy provider
    Q4 2024Quarterly · 2024-03-31GeographyOtherforeignlocations360,718,000USDLegacy provider
    Q4 2024Quarterly · 2024-03-31GeographyUnited States1,036,004,000USDLegacy provider
    FY 2024Yearly · 2024-03-31ProductCapitalequipmentrevenues1,261,576,000USD0001757898-24-000008
    FY 2024Yearly · 2024-03-31ProductConsumablerevenues1,500,004,000USD0001757898-24-000008
    FY 2024Yearly · 2024-03-31ProductServicerevenues2,377,121,000USD0001757898-24-000008
    Q4 2024Quarterly · 2024-03-31ProductProduct786,283,000USDLegacy provider
    Q4 2024Quarterly · 2024-03-31ProductServices633,103,000USDLegacy provider
    FY 2024Yearly · 2024-03-31SegmentApplied Sterilization Technologies954,000,000USD0001628280-26-039136
    FY 2024Yearly · 2024-03-31SegmentHealthcare3,613,000,000USD0001628280-26-039136
    FY 2024Yearly · 2024-03-31SegmentLife Science Member571,700,000USD0001628280-26-039136
    Q3 2024Quarterly · 2023-12-31SegmentApplied Sterilization Technologies234,931,000USD0001757898-25-000002
    Q3 2024Quarterly · 2023-12-31SegmentHealthcare Member916,227,000USD0001757898-25-000002
    Q3 2024Quarterly · 2023-12-31SegmentLife Science Member146,566,000USD0001757898-25-000002
    Q2 2024Quarterly · 2023-09-30SegmentApplied Sterilization Technologies235,053,000USD0001757898-24-000018
    Q2 2024Quarterly · 2023-09-30SegmentHealthcare Member870,056,000USD0001757898-24-000018
    Q2 2024Quarterly · 2023-09-30SegmentLife Science Member133,095,000USD0001757898-24-000018
    Q1 2024Quarterly · 2023-06-30SegmentApplied Sterilization Technologies233,099,000USD0001757898-24-000016
    Q1 2024Quarterly · 2023-06-30SegmentHealthcare Member818,874,000USD0001757898-24-000016
    Q1 2024Quarterly · 2023-06-30SegmentLife Science Member131,413,000USD0001757898-24-000016
    FY 2023Yearly · 2023-03-31GeographyIE74,292,000USD0001757898-25-000005
    FY 2023Yearly · 2023-03-31GeographyOtherforeignlocations1,207,601,000USD0001757898-25-000005
    FY 2023Yearly · 2023-03-31GeographyUnited States3,254,373,000USD0001757898-25-000005
    FY 2023Yearly · 2023-03-31ProductCapitalequipmentrevenues1,070,470,000USD0001757898-24-000008
    FY 2023Yearly · 2023-03-31ProductConsumablerevenues1,291,430,000USD0001757898-24-000008
    FY 2023Yearly · 2023-03-31ProductServicerevenues2,174,366,000USD0001757898-24-000008
    FY 2022Yearly · 2022-03-31GeographyIE81,864,000USD0001757898-24-000008
    FY 2022Yearly · 2022-03-31GeographyOtherforeignlocations1,197,589,000USD0001757898-24-000008
    FY 2022Yearly · 2022-03-31GeographyUnited States2,943,950,000USD0001757898-24-000008
    FY 2022Yearly · 2022-03-31ProductCapitalequipmentrevenues949,180,000USD0001757898-24-000008
    FY 2022Yearly · 2022-03-31ProductConsumablerevenues1,243,970,000USD0001757898-24-000008

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.